- Home
- XERS vs SXC Comparison
XERS vs SXC Comparison
Compare XERS & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- SXC
- Stock Information
- Founded
- XERS 2005
- SXC 1960
- Country
- XERS United States
- SXC United States
- Employees
- XERS N/A
- SXC N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- SXC Steel/Iron Ore
- Sector
- XERS Health Care
- SXC Industrials
- Exchange
- XERS Nasdaq
- SXC Nasdaq
- Market Cap
- XERS 628.7M
- SXC 725.5M
- IPO Year
- XERS 2018
- SXC N/A
- Fundamental
- Price
- XERS $5.07
- SXC $8.22
- Analyst Decision
- XERS Strong Buy
- SXC Strong Buy
- Analyst Count
- XERS 6
- SXC 1
- Target Price
- XERS $6.25
- SXC $13.00
- AVG Volume (30 Days)
- XERS 2.2M
- SXC 775.4K
- Earning Date
- XERS 05-08-2025
- SXC 04-30-2025
- Dividend Yield
- XERS N/A
- SXC 5.90%
- EPS Growth
- XERS N/A
- SXC 51.30
- EPS
- XERS N/A
- SXC 1.09
- Revenue
- XERS $222,551,000.00
- SXC $1,883,000,000.00
- Revenue This Year
- XERS $33.96
- SXC N/A
- Revenue Next Year
- XERS $19.87
- SXC $0.99
- P/E Ratio
- XERS N/A
- SXC $7.47
- Revenue Growth
- XERS 29.88
- SXC N/A
- 52 Week Low
- XERS $1.96
- SXC $7.47
- 52 Week High
- XERS $6.07
- SXC $12.82
- Technical
- Relative Strength Index (RSI)
- XERS 54.35
- SXC 39.37
- Support Level
- XERS $4.71
- SXC $8.04
- Resistance Level
- XERS $5.09
- SXC $9.07
- Average True Range (ATR)
- XERS 0.22
- SXC 0.19
- MACD
- XERS -0.00
- SXC -0.04
- Stochastic Oscillator
- XERS 58.93
- SXC 27.18
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.